Soraprazan - a new regenerative therapy for Stargardt's disease

Project Information

Soraprazan

Grant agreement ID: 779317

DOI

10.3030/779317

Project closed

EC signature date 15 November 2017

Start date 1 December 2017

End date 30 November 2021

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost

€ 5 792 425,00

EU contribution

€ 5 792 425,00

Coordinated by

EBERHARD KARLS UNIVERSITAET TUEBINGEN
Germany

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Websites, patent fillings, videos etc. (1)

Project Website

Public web-site launch of Soraprazan project to increase patients’ awareness

Publications

Peer reviewed articles (2)

The STArgardt Remofuscin Treatment Trial (STARTT): design and baseline characteristics of enrolled Stargardt patients

Author(s): Patty P.A. Dhooge, Philipp T. Möller, Camiel J.F. Boon, Andrew J. Lotery, Philipp Herrmann, Maurizio Battaglia Parodi, Wolfgang Klein, Mario G. Fsadni, Thomas H. Wheeler-Schilling, Oliver Jungmann, Hans Müller, Frank G. Holz, Steffen Schmitz-Valckenberg, Tobias M. Peters, Katarina Stingl,15, Carel B. Hoyng, Soraprazan Consortium
Published in: Open Research Europe, 2021, ISSN 2732-5121
Publisher: European Commission
DOI: 10.12688/openreseurope.13872.1

Evaluation of Local Rod and Cone Function in Stargardt Disease

Author(s): Stingl, Krunoslav; Hoyng, Carel; Kempf, Melanie; Kohl, Susanne; Jung, Ronja; Righetti, Giulia; Kühlewein, Laura; Pohl, Lisa; Kortüm, Friederike; Kelbsch, Carina; Wilhelm, Barbara; Peters, Tobias; Stingl, Katarina; on behalf of the SORAPRAZAN consortium
Published in: Investigative ophthalmology & visual science, Issue 63 (3), 2022, ISSN 0146-0404
Publisher: Association for Research in Vision and Ophthalmology
DOI: 10.1167/iovs.63.3.6